Heterogeneous components of lung adenocarcinomas confer distinct EGFR mutation and PD-L1 expression | BMC Cancer | Full Text

Heterogeneous components of lung adenocarcinomas confer distinct EGFR mutation and PD-L1 expression | BMC Cancer | Full Text

Heterogeneous components of lung adenocarcinomas confer distinct EGFR mutation and PD-L1 expression

Lung adenocarcinoma (LAC) is composed of lepidic, papillary, mucinous, micropapillary and solid components in its parenchyma. Complex responses to therapeutics result from intratumoral heterogeneity. However, ...

Authors:Yiran Cai, Hongbo Wu, Xiaoqin Shi, Yujie Dong, Xiujun Chang, Li Zhang, Lijuan Zhou, Dan Su and Ming Yang

Citation:BMC Cancer 2020 20:148

Content type:Research article

Published on: 24 February 2020

• ViewFull Text
 
• ViewPDF